Women Have Lower Risk for Death After Resection for Lung Cancer
Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection
Industry Payments Consistently Linked to Physician Prescribing
Thirty of 36 studies identified a positive association between payments and prescribing in all analyses
Risk for SARS-CoV-2 Infection Lower for O, Rh− Blood Groups
Also, risk for severe COVID-19 illness or death lower for O versus all other groups, for Rh− versus Rh+
Colon Cancer Diagnosed Earlier Under Medicaid Expansion
Medicaid expansion also may result in improved access to treatment, including palliative care
Cardiorespiratory Fitness Reduced With Prolonged ADT in Prostate Cancer
Increased cardiovascular mortality also seen with prolonged androgen deprivation therapy for prostate cancer
COVID-19 Outcomes Not Improved With Convalescent Plasma
Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
Breast Cancer, CRC Incidence No Different With, Without MS
However, bladder cancer incidence and mortality rates higher among individuals with multiple sclerosis
ART Treatment Not Tied to Higher Risk for Ovarian Cancer
Increased risk compared with general population likely due to nulliparity among ART-treated women; risk not increased versus subfertile women
RSNA: Deep Learning Model Can Predict Breast Cancer Risk
DL model using screening mammography biomarkers can improve accuracy for predicting future breast cancer risk
